Diseases » Pneumococcal pneumonia » Prevention

Prevention of Pneumococcal pneumonia

Prevention of Pneumococcal pneumonia:

Methods of prevention of Pneumococcal pneumonia mentioned in various sources includes those listed below. This prevention information is gathered from various sources, and may be inaccurate or incomplete. None of these methods guarantee prevention of Pneumococcal pneumonia.

• Polysaccharide pneumococcal vaccine - older vaccine; not for under 2 years.
• Conjugate pneumococcal vaccine - newer vaccine that works for infants.

Clinical Trials for Pneumococcal pneumonia

Some of the clinical trials for Pneumococcal pneumonia include:

• New Antibiotic to Treat Patients With Community-Acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) - This study has been completed (Current: 23 Nov 2006) - Antibiotic
• Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals - This study has been completed (Current: 23 Nov 2006) - Lamivudine
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-Valent Pneumococcal Conjugate Vaccine - This study is currently recruiting patients (Current: 23 Nov 2006)
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals 10-Valent Pneumococcal Conjugate Vaccine. - This study is currently recruiting patients (Current: 23 Nov 2006)
• Humoral Determinants of Immunity to Pneumococcal Infection - This study is currently recruiting patients (Current: 23 Nov 2006)
• more clinical trials...»

Treatments for Pneumococcal pneumonia

Treatments to consider for Pneumococcal pneumonia may include:

• Antibiotics
• more treatments...»

Prevention of Pneumococcal pneumonia:

The pneumococcal vaccine is the only way to prevent getting pneumococcal pneumonia. Vaccines are available for children and adults.

The CDC National Immunization Program (NIP) recommends that you get immunized against pneumococcal pneumonia if you are in any of the following groups.

• You are 65 years old or older.
• You have a serious long-term health problem such as heart disease, sickle cell disease, alcoholism, leaks of cerebrospinal fluid, lung disease (not including asthma), diabetes, or liver cirrhosis.
• Your resistance to infection is lowered due to HIV infection or AIDS; lymphoma, leukemia, or other cancers; cancer treatment with x-rays or drugs; treatment with long-term steroids; bone marrow or organ transplant; kidney failure; nephrotic (kidney) syndrome; damaged spleen or no spleen.
• You are an Alaskan-Native or from certain Native-American populations.

In February 2000, the U.S. Food and Drug Administration approved a pneumococcal vaccine for use in toddlers and children. It is the first pneumococcal vaccine approved for children younger than 2 years old [http://www.fda.gov/cber/inside/annrpt.htm,: CBER Annual Report FY2000 Issued:01-08-01, Posted: 03-15-01, Updated: 04-10-01]. NIP recommends that all children ages 2 to 23 months old get this vaccine. (Source: excerpt from Pneumococcal Pneumonia, NIAID Fact Sheet: NIAID)

Prevention Claims: Pneumococcal pneumonia

Information on prevention of Pneumococcal pneumonia comes from many sources. There are some sources that claim preventive benefits for many different diseases for various products. We may present such information in the hope that it may be useful, however, in some cases claims of Pneumococcal pneumonia prevention may be dubious, invalid, or not recognized in mainstream medicine. Please discuss any treatment, discontinuation of treatment, or change of treatment plans with your doctor or professional medical specialist.

homepage | back to top

Search Specialists by State and City

Choose... GENERAL PRACTICE CARDIAC HEALTH WOMEN'S HEALTH CANCER CARE RADIOLOGY MENTAL HEALTH PATHOLOGY EAR, NOSE, THROAT MEDICINE GENETICS NEUROLOGY DIALYSIS CARE SURGERY ORTHOPEDICS/SPORTS MEDICINE CHILDREN'S HEALTH OTHER SPECIALTIES